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Considered in the paper is the problem of selecting a diagnostic biomarker that has the
highest classiﬁcation rate among several candidate markers with dichotomous outcomes.
The probability of correct selection depends on a number of nuisance parameters from
the joint distribution of the biomarkers and thus can be substantially affected if these
nuisance parameters are misspeciﬁed. A two-stage procedure is proposed to compute the
needed sample size that achieves the desired level of correct selection, as so conﬁrmed by
simulation results.
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1. Introduction
In the area of diagnostic medicine, a biomarker is used to identify subjects that
have a certain condition, e.g. a disease or risk status for the disease, so that
proper treatments can be followed (Zhou et al. 2002). Often, multiple candidate
biomarkers are developed simultaneously and medical investigators are
interested in selecting the one with the highest diagnostic accuracy among
these newly identiﬁed biomarkers so that future studies can be focused on the
selected biomarker.
One approach to achieving this goal is as follows. A number of subjects are
randomly selected from a population with the condition and one without the
condition, hereafter referred to as ‘diseased’ and ‘non-diseased’ populations,
respectively. The candidate biomarkers are then tested on each subject and their
diagnostic accuracy is evaluated from the test results. The biomarker that yields
the highest (estimated) accuracy will then be identiﬁed as the best biomarker.
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correct selection (PCS), that is, the probability that the selected biomarker
indeed has the highest diagnostic accuracy. The number of diseased and non-
diseased subjects needs to be sufﬁciently large so that the PCS can be maintained
at a certain desired level. Since the biomarkers are tested on the same subject,
their test outcomes from the same subject are correlated, following a multivariate
distribution. Thus, the PCS depends on a number of parameters from the
joint distribution which have to be speciﬁed in order to have an estimate of the
sample size. Unfortunately, however, the PCS can be substantially adversely
affected if these parameters are not correctly quantiﬁed.
To relax the dependence of the PCS on these parameters, we propose a two-
stage procedure. First, we randomly select a number of diseased and non-
diseased subjects and use the test results from these subjects to estimate the
corresponding parameters in the PCS function. Then, the total number of
diseased and non-diseased subjects is computed using these estimates that
achieve the desired PCS level when the diagnostic accuracy of the best biomarker
differs from the other biomarkers by a speciﬁed amount. Simulation results are
presented to demonstrate the effectiveness of the proposed procedure in
achieving the PCS. This paper ends with some discussions in §6.
2. Formulation of the problem
Suppose there are K candidate biomarkers under consideration, and each yields a
binary test result on a subject, 1 or 0, representing the subject being classiﬁed as
diseased or non-diseased, respectively, by the biomarker. To assess their diagnostic
accuracy, these biomarkers are tested on a random sample of m diseased and n non-
diseased subjects. For the kth biomarker, its test result is denoted by Xik from the
ith diseased subject and Yjk from the jth non-diseased subject. With these
notations, the sensitivity (the probability of correctly classifying a diseased subject)
of the kth biomarker is pkZPfXikZ1g and can be estimated by ^ pkZ
Pm
iZ1 Xik=m.
Its speciﬁcity (the probability of correctly classifying a non-diseased subject) is
PfYjkZ0gZ1Kqk,w i t hqkZPfYjkZ1g and can be estimated by 1K^ qk,w i t h
^ qkZ
Pn
jZ1 Yjk=n. The classiﬁcation rate qk of the kth biomarker is the sum of the
two quantities, i.e. qkZpkKqkC1 ZPfXikZ1gKPfYjkZ1gC1, and can be
estimated subsequently by ^ qkZ
Pm
iZ1 Xik ðÞ =m K
Pn
jZ1 Yjk
  
=nC1. The best
biomarker is the one with the largest q, and the one that yields the largest
q-estimate will be chosen as the ‘best’ biomarker. Selection error occurs when the
largest q-estimate is not from the biomarker with the largest q.
Without loss of generality, we assume that the ﬁrst biomarker is the best
among the candidate markers, i.e. q1ZmaxkR1qk. The lth biomarker is selected
as the best if ^ qlZmaxkR1^ qk: Therefore, the PCS is
r ZP ^ q1 Zmax
kR1
^ qk
       q1 Zmax
kR1
qk
  
:
The key issue is to determine m and n so that the PCS will be at least g,a
speciﬁed level of probability, under certain parametric conﬁguration of the qs.
Usually we require that rRg when q1KmaxkR2qkRD, where DO0 is also a
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asymptotically a multivariate normal distribution. Thus if rZg for
q1KmaxkR2qkZD, then rRg for q1KmaxkR2qkRD. Therefore, the sample
sizes m and n are computed by solving the equation
P ^ q1 Zmax
kR1
^ qk
       q1Kmax
kR2
qk ZD
  
Zg:
In order to compute the sample sizes, parameters other than D which appear in
the equation are given values based on ‘educational guess’ or other data sources
if possible.
3. Computation of PCS
The test outcomes of the K biomarkers from a diseased or non-diseased subject
follow a multinomial distribution. Exact calculation of the PCS involves the joint
probabilities of {Xi1Z0o r1 ,., XiKZ0 or 1} and {Yj1Z0o r1 ,., YjKZ0 or 1},
which becomes extremely complicated when K is relatively large. Instead,
we may use normal approximation to relax the computational complexity,
assuming that the sample sizes are relatively large.
Write qZðq1;.;qKÞ and ^ qZð^ q1;.; ^ qKÞ. Then by classical asymptotic theory
(Bickel & Doksum 1977), ^ q follows asymptotically a multivariate normal
distribution with mean vector q and a variance-covariance matrix given by
varð^ qkÞ Z
1
m
pkð1KpkÞC
1
n
qkð1KqkÞ
and
covð^ qk; ^ qlÞ Z
1
m
ðpk;lKpkplÞC
1
n
ðqk;lKqkqlÞ;
where pk;lZPfX1kZX1lZ1g;qk;lZPfY1kZY1lZ1g.
Deﬁne dkZqkC1Kq1 and ^ dkZ^ qkC1K^ q1, for kZ1;.;K K1, and write dZ
ðd1;.;dKK1Þ and ^ dZð^ d1;.; ^ dKK1Þ. Then ^ d is also normally distributed with
mean vector d and variance-covariance matrix SZðsklÞ, where
skk Zvarð^ dkÞ Z
1
m
pkC1 Cp1K2p1;kC1Kðp1KpkC1Þ
2   
C
1
n
qkC1 Cq1K2q1;kC1Kðq1KqkC1Þ
2   
and
skl Z
1
m
pkC1;lC1Kp1;kC1Kp1;lC1 Cp1Kðp1KpkC1Þðp1KplC1Þ
  
C
1
n
qkC1;lC1Kq1;kC1Kq1;lC1 Cq1Kðq1KqkC1Þðq1KqlC1Þ
  
:
Let Fðx1;.;xKK1;d;SÞ be the multivariate normal distribution function with
mean d and variance-covariance matrix S, then the PCS is approximately
rðd;SÞ ZP ^ dk%0;k Z1;.;K K1
no
ZFð0;.;0;d;SÞ: ð3:1Þ
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under the constraints that dkZD for all kZ1;.;KK1.
4. A two-stage procedure
The asymptotic formula (3.1) of the PCS involves K(KC1) parameters
fpk;qk;pk;l;qk;l : 1%k;l%K;lskg from the multinomial distributions. With
the KK1 constraints dkZD, there are K
2C1 distributional parameters (referred
to as nuisance parameters) left to be speciﬁed in order to solve for sample sizes,
assuming that m/nZl is a known constant. If these nuisance parameters are
misspeciﬁed, then the PCS can be substantially adversely affected, resulting in
an unacceptably high level of selection error; see §5 for numerical demonstration.
In order to maintain the desired level of the PCS, we propose, following Stein’s
(1945) idea, a two-stage selection procedure to compute the required sample size
NZmCnZ(1Cl)n with ratio lZm/n ﬁxed.
Step 1. Randomly select m1 diseased and n1 non-diseased subjects from the
target populations and test the biomarkers on these subjects. Use the test
outcomes Xik, iZ1, ., m1 and Yjk, jZ1, ., n1 to obtain empirical estimates of
the nuisance parameters, given as follows:
^ pk Z
1
m1
X m1
iZ1
Xik; ^ qk Z
1
n1
X n1
jZ1
Yjk; ð4:1Þ
^ pk;l Z
1
m1
X m1
iZ1
XikXil; ^ qk;l Z
1
n1
X n1
jZ1
YjkYjl: ð4:2Þ
Step 2. Plug these estimates into the PCS formula and then solve for sample
size N 0 from the equation rZg. The required sample size N is then set to
max(N1, N 0), with N1Zm1Cn1.
The sample size N computed in this way is no longer a ﬁxed quantity. Rather,
it is a random variable, a statistic of the data from the ﬁrst stage. Note that the
estimates in (4.1) and (4.2) are consistent estimators of the corresponding
parameters. For sufﬁcient sample size N1, the PCS is expected to be
approximately g regardless of the true values of the nuisance parameters; see
simulation results below.
5. Numerical evaluation
Numerical studies are conducted to investigate the effects of the nuisance
parameters on PCS and the performance of the proposed two-stage procedure in
maintaining the level of PCS. To reduce the computational burden, we use three
biomarkers (KZ3) for illustration.
Table 1 presents the values of PCS under various conﬁgurations of the
parameter space which determine the joint distribution of the three
biomarkers, that is, the joint probability of pijkZPfX11Zi;X12Zj;X13Zkg
and qijkZPfY11Zi;Y12Zj;Y13Zkg, for i, j, kZ0, 1. These joint probabilities
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p1;2 ZPfX11 Z1;X12 Z1g Zp111 Cp110
p1 ZPfX11 Z1g Zp111 Cp110 Cp101 Cp100;
and so on.
All conﬁgurations in table 1 correspond to a ﬁxed value of 0.1 for
DðZq1Kq2Zq1Kq3Þ. The ﬁrst row in the table speciﬁes the parameters
used to compute the sample size, for a single-stage procedure, assuming that
lZm/nZ1. It turns out that, with this conﬁguration, 102 diseased and 102 non-
diseased subjects are needed to achieve a PCS of at least 0.95.
The r-values, computed using formula (3.1), in the remaining rows of table 1
are the PCS with 102 diseased and 102 non-diseased subjects under other
speciﬁcations of the parameter values. We see that the PCS can be substantially
lower than the desired level of 0.95 if the parameters differ from the speciﬁed
values in the ﬁrst row of the table. For example, if the corresponding parameters
from the joint distribution of the three biomarkers take values from the second
row rather than as being speciﬁed in the ﬁrst row of the table, then the PCS can
be decreased by more than 20%!
To investigate whether the proposed two-stage procedure can relax the
dependence on nuisance parameters and maintain the PCS at the desired level,
we conducted 10 000 simulations for each conﬁguration of the parameter space in
table 1. The simulated values of PCS are presented as r
  in the last column of the
table. For the ﬁrst-stage sample size, we used m1Z75 diseased and n1Z75 non-
diseased subjects to estimate the corresponding nuisance parameters.
The results in table 1 clearly show that the PCS is maintained at the desired
level of 0.95, regardless of the parametric conﬁguration under which the data are
generated. Thus the two-stage procedure is proved to be efﬁcient in controlling
selection error rates. Numerical results (not shown here) for other conﬁgurations
and ratios of l reveal similar ﬁndings. With such a multidimensional parameter
space, however, it is difﬁcult to characterize any conﬁgurations for which the
two-stage procedure would perform relatively better.
6. Discussion
In this paper, we proposed a two-stage procedure to select the best diagnostic
biomarker among a number of candidate markers, and numerically demonstrated
its effectiveness in controlling the selection error. While there is no universal
standard on how the ﬁrst-stage sample size is determined, it should be relatively
large so that accurate estimates of the nuisance parameters can be obtained. On
the other hand, it should not be too large when taking the cost effectiveness of a
study into consideration.
We conﬁne our attention to biomarkers with dichotomous outcomes. However,
the two-stage approach proposed in this paper can be easily extended to
biomarkers with ordinal or continuous test results. In these two cases, an
appealing selection criterion is to select the marker that has the largest area
under its receiver operating characteristic curve (Hanley 1989).
A. Liu et al. 2298
Phil. Trans. R. Soc. A (2008)Various selection problems and related procedures have been discussed
extensively in the statistical literature (see Bechhofer et al. 1968; Gibbons 1988),
but mostly focusing on multivariate normal distributions. Applications of the
selection concepts and theory to the area of diagnostic medicine are relatively
new, and many other issues remain to be solved such as selecting a ﬁxed number
of best diagnostic biomarkers and selecting the best biomarker (or all
biomarkers) that are better than a standard biomarker. Further research efforts
are much needed along these lines.
Throughout this paper we assume that the data will be available for all
biomarkers from each subject. Very often values on some biomarkers may be
missing. One possible approach to dealing with this situation is to use multiple
imputation based on the multinomial distributions and then apply the proposed
method to the imputed data. The effectiveness of this approach in controlling the
PCS needs further investigation. Moreover, selection bias may occur when the
subjects are not randomly selected, and correction for such bias in estimating the
PCS is desirable.
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